Second generation analogues of RKA182: synthetic tetraoxanes with outstanding in vitro and in vivo antimalarial activities
暂无分享,去创建一个
A. Srivastava | R. Amewu | James Chadwick | A. Srivastava | Raman Sharma | N. Berry | S. Ward | P. O’Neill | Francesc Martí | Hollie Burrell-Saward
[1] Christian Scheurer,et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria , 2011, Proceedings of the National Academy of Sciences.
[2] Zu-feng Guo,et al. Reactions of Antimalarial Peroxides with Each of Leucomethylene Blue and Dihydroflavins: Flavin Reductase and the Cofactor Model Exemplified , 2011, ChemMedChem.
[3] Ian D. Williams,et al. Facile Oxidation of Leucomethylene Blue and Dihydroflavins by Artemisinins: Relationship with Flavoenzyme Function and Antimalarial Mechanism of Action , 2010, ChemMedChem.
[4] B. K. Park,et al. Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins. , 2010, Angewandte Chemie.
[5] J. Chollet,et al. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277). , 2010, Journal of medicinal chemistry.
[6] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.
[7] P. Dussault,et al. Broadly applicable synthesis of 1,2,4,5-tetraoxanes. , 2009, Organic letters.
[8] Ruth H. Hughes,et al. Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs. , 2007, Angewandte Chemie.
[9] R. Amewu,et al. Design and synthesis of orally active dispiro 1,2,4,5-tetraoxanes; synthetic antimalarials with superior activity to artemisinin. , 2006, Organic & biomolecular chemistry.
[10] Christopher M. Clouthier,et al. New bioorganic reagents: evolved cyclohexanone monooxygenase--why is it more selective? , 2006, The Journal of organic chemistry.
[11] Christian Scheurer,et al. Identification of an antimalarial synthetic trioxolane drug development candidate , 2004, Nature.
[12] X. Su,et al. Genetic and biochemical aspects of drug resistance in malaria parasites. , 2004, Current drug targets. Infectious disorders.
[13] D. Bonnet-Delpon,et al. One-pot synthesis of non-symmetric tetraoxanes with the H2O2/MTO/fluorous alcohol system , 2003 .
[14] Y. Wataya,et al. Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. , 2001, Journal of medicinal chemistry.
[15] M. Nojima,et al. Recent Advances in the Chemistry of Cyclic Peroxides , 2001 .
[16] B. Meunier,et al. Characterization of the Alkylation Product of Heme by the Antimalarial Drug Artemisinin , 2001 .
[17] J. K. Wood,et al. Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes. , 2000, Journal of medicinal chemistry.
[18] Hye-Sook Kim,et al. Synthesis, crystal structure and anti-malarial activity of functionalized spiro-1,2,4,5-tetraoxacycloalkanes from unsaturated hydroperoxy peracetals , 2000 .
[19] Hye-Sook Kim,et al. Synthesis, crystal structure and anti-malarial activity of novel spiro- 1,2,4,5-tetraoxacycloalkanes , 1999 .
[20] J. K. Wood,et al. Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999. 7,8,15,16-Tetraoxadispiro[5.2.5.2]hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups. , 1999, Journal of medicinal chemistry.
[21] Yuxiang Dong,et al. Dispiro-1,2,4,5-tetraoxanes via Ozonolysis of Cycloalkanone O-Methyl Oximes: A Comparison with the Peroxidation of Cycloalkanones in Acetonitrile−Sulfuric Acid Media , 1998 .
[22] J. K. Wood,et al. Dispiro-1,2,4,5-tetraoxanes: a new class of antimalarial peroxides. , 1992, Journal of medicinal chemistry.
[23] Yuxiang Dong. Synthesis and antimalarial activity of 1,2,4,5-tetraoxanes. , 2002, Mini reviews in medicinal chemistry.
[24] W. Milhous,et al. Antimalarial peroxides: the first intramolecular 1,2,4,5-tetraoxane , 2002 .